Rarity Bioscience - Latest updates

Click Here to Download the MRD Poster Rarity Bioscience’s Alexander Kele and Ann-Sofi Johansson attended the biannual ESH AML Conference,

Download the full presentation Our own CTO, Lei Chen, held an award winning presentation at ESCCA 2023 in Utrecht, “Ultra-sensitive molecular MRD

Read the full abstract here We are thrilled to share that Rarity Bioscience together with Karolinska Institutet and Uppsala University

Rarity offers ultra-sensitive and multiplexed mutation detection on 21 of the most common KRAS hotspot mutations for liquid biopsy research.

We can now proudly announce that Rarity Bioscience have achieved the ISO 13485:2016 certification from BSI! The achievement emphasizes Rarity

Industry case by SciLifeLab: Rarity Bioscience and SciLifeLab are collaborating to advance superRCA, a powerful tool for nucleic acid detection.

New perspective article on Liquid Biopsy using superRCA, from Uppsala University and Karolinska Institute: This perspective article compares existing techniques

Per Matsson, an esteemed biotechnology leader, has been appointed as the new chairman of the Board at Rarity Bioscience. His

CEO Linus Bosaeus, CTO Lei Chen and Dir. BD Alexander Kele attended the ISMRC (International Symposium on Minimal Residual Cancer) Conference in Hamburg,

CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the AML Conference in Munich, Germany 2023, to engage

Using the superRCA technology, you can essentially detect any known sequence of interest using target specific ligation templates and padlock

Last spring, Rarity was awarded a grant from Swelife and Medtech4Health. The idea is to study superRCA for precision diagnostics

To further accelerate growth, Rarity Bioscience announces today a new strategicinvestment from Belgium based Novalis Biotech. The investment is facilitated

With the aim to improve cancer diagnostics, Rarity Bioscience has raised €2,5 million to expand operations and product development within

During November, Rarity Bioscience offer free analysis of liquid biopsy samples for cancer research. Movember is a month-long event to

Speed of Life is a podcast series focusing on innovations accelerating towards better health, by STUNS Life Science. It’s sponsored

Rarity Bioscience was founded in July 2021 based on an innovation by Dr. Lei Chen and Professor Ulf Landegren. Linus

CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the European Society for Medical Oncology Congress 2022, to